Leukemia & Lymphoma
Latest Publications

TOTAL DOCUMENTS

12626
(FIVE YEARS 990)

H-INDEX

81
(FIVE YEARS 4)

Published By Informa Uk (Taylor & Francis)

1029-2403, 1042-8194
Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

2022 ◽  
pp. 1-5
Author(s):  
Trine Engelbrecht Hybel ◽  
Maja Ølholm Vase ◽  
Kristina Lystlund Lauridsen ◽  
Marie Beck Enemark ◽  
Michael Boe Møller ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Potential Treatment ◽  
Treatment Target ◽  
Immunodeficiency Virus

Lymphocyte HLA-DR/CD-38 co-expression correlates with Hodgkin lymphoma cell cytotoxicity in vitro independent of PD-1/PD1-L pathway

2022 ◽  
pp. 1-8
Author(s):  
Meret Henry ◽  
Steven Buck ◽  
Batool Al-Qanber ◽  
Manisha Gadgeel ◽  
Süreyya Savasan
Keyword(s):  
Hodgkin Lymphoma ◽  
Lymphoma Cell ◽  
Cell Cytotoxicity ◽  
Hla Dr ◽  
Hodgkin Lymphoma Cell

Second primary malignancy risk after Hodgkin lymphoma treatment among HIV-uninfected and HIV-infected survivors

2022 ◽  
pp. 1-11
Author(s):  
Renata Abrahão ◽  
Ann M. Brunson ◽  
Justine M. Kahn ◽  
Qian W. Li ◽  
Ted Wun ◽  
...  
Keyword(s):  
Hodgkin Lymphoma ◽  
Second Primary ◽  
Second Primary Malignancy ◽  
Primary Malignancy ◽  
Malignancy Risk ◽  
Lymphoma Treatment

Improving outcomes in limited-stage de novo CD5+ DLBCL: systemic approaches with consolidative radiation

2022 ◽  
pp. 1-6
Author(s):  
Jurui Ge ◽  
Yaqin Xia ◽  
Zhenchang Sun ◽  
Lei Zhang ◽  
Xin Li ◽  
...  
Keyword(s):  
De Novo ◽  
Limited Stage
Load More ...
Sign in / Sign up

Export Citation Format

Share Document